Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Douglas R, Dixon"'
Autor:
Gustavo Avila‐Ortiz, Jeanne Ambruster, Shayan Barootchi, Leandro Chambrone, Chia‐Yu Chen, Douglas R. Dixon, Maria L. Geisinger, William V. Giannobile, Katie Goss, John C. Gunsolley, Rick H. Heard, David M. Kim, George A. Mandelaris, Alberto Monje, Marc L. Nevins, Angela Palaiologou‐Gallis, Paul S. Rosen, E. Todd Scheyer, Fernando Suarez‐Lopez del Amo, Lorenzo Tavelli, Diego Velasquez, Hom‐Lay Wang, Brian L. Mealey
Publikováno v:
Journal of Periodontology. 93:1763-1770
A biologic is a therapeutic agent with biological activity that is administered to achieve an enhanced regenerative or reparative effect. The use of biologics has progressively become a core component of contemporary periodontal practice. However, so
Publikováno v:
Journal of dental educationREFERENCES.
Autor:
Douglas R. Dixon, Alaa Yassin
Publikováno v:
Clinical Advances in Periodontics. 10:123-129
Introduction Little is known regarding maintaining free gingival margin stability after immediate implant placement. Therefore, we present a sequential technique incorporating a sectional connective tissue graft with an emergence tissue provisional t
Autor:
Martin Prlic, Brittany Barber, Andrew J. Konecny, Florian Mair, Jami R. Erickson, Evan Greene, Douglas R. Dixon, Marie Frutoso, Raphael Gottardo, Valentin Voillet
Immunotherapies to treat cancer have achieved remarkable successes, but major challenges persist. An inherent weakness of current treatment approaches is that therapeutically targeted pathways are not only found in tumors, but also in tissue microenv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2964b42029b93b9063bf2b82f00f8275
https://doi.org/10.21203/rs.3.rs-356214/v1
https://doi.org/10.21203/rs.3.rs-356214/v1
Autor:
Chloe K. Slichter, Rhonda M. Brand, Martin Prlic, Alexis Klock, Douglas R. Dixon, Hayley N. Roozen, Peter S. Linsley, Yu Lwo, Amanda S. Woodward Davis, Julia D. Berkson, Matthew J. Dufort, Florian Mair, Jami R. Erickson, Hannah A. DeBerg, Martha A. Delaney, Alexander Ko, Matthias Mack, Ian Michael McGowan
Publikováno v:
Science Translational Medicine. 11
CCR5 is thought to play a central role in orchestrating migration of cells in response to inflammation. CCR5 antagonists can reduce inflammatory disease processes, which has led to an increased interest in using CCR5 antagonists in a wide range of in
Autor:
Alaa Yassin, Douglas R. Dixon
Publikováno v:
Clinical Advances in Periodontics. 7:115-120
Little is known regarding the success, failure, or complication rates of advanced implant procedures in patients after discontinuation therapy of long-term medications for the treatment of chronic myelogenous leukemia (CML). This case report presents
Autor:
Peter S. Linsley, Chloe K. Slichter, Jessica J. Hsu, Yu-Wen Chiu, Martin Prlic, Yu Lwo, Hannah A. DeBerg, Martha A. Delaney, Nicholas J. Maurice, Douglas R. Dixon, Julia D. Berkson, Amanda Woodward-Davis, Alex Ko
Publikováno v:
Immunohorizons
Mucosal-associated invariant T (MAIT) cells acquire effector function in response to proinflammatory signals, which synergize with TCR-mediated signals. We asked if cell-intrinsic regulatory mechanisms exist to curtail MAIT cell effector function aki
Autor:
Robert M. London, Douglas R. Dixon
Publikováno v:
Periodontology 2000. 81(1)
The prevalence of inflammatory conditions around dental implants is significant. Current analysis indicates that the rates for peri-mucositis and peri-implantitis may be as high as 40%-65% and 20%-47%, respectively. Over the last decade, many risk fa
Autor:
Amanda S, Woodward Davis, Hayley N, Roozen, Matthew J, Dufort, Hannah A, DeBerg, Martha A, Delaney, Florian, Mair, Jami R, Erickson, Chloe K, Slichter, Julia D, Berkson, Alexis M, Klock, Matthias, Mack, Yu, Lwo, Alexander, Ko, Rhonda M, Brand, Ian, McGowan, Peter S, Linsley, Douglas R, Dixon, Martin, Prlic
Publikováno v:
Sci Transl Med
C - C chemokine receptor type 5 (CCR5) is thought to play a central role in orchestrating migration of cells in response to inflammation. CCR5 antagonists can reduce inflammatory disease processes which has led to an increased interest in using CCR5
Publikováno v:
Clinical advances in periodontics. 6(1)
Close clinical inspection for intraoral lesions in patients with leukemia that develop chronic graft-versus-host disease (cGVHD) is critical. Additionally, neoplasias developing in bone marrow transplant patients after treatment for leukemia represen